Innovasive™ Announces Name Change to Amplify Surgical

Thursday, February 14, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

The Amplify Surgical Name Better Represents Company's Innovative Culture

MISSION VIEJO, Calif., Feb. 14, 2019 /PRNewswire-PRWeb/ -- Innovasive, a privately-held spinal device company that focuses

on developing and commercializing minimally-invasive, innovative spinal technologies, today announced a corporate rebrand and name change to Amplify Surgical, Inc.

"The Amplify Surgical name better emphasizes our commitment to delivering new, cutting-edge, surgical solutions that reestablish the standard of care for our surgeon customers and their patients," explained Andy Choi, Chief Executive Officer, Innovasive, Inc. "In addition, the new name and brand better represents the Company's inventive culture and product pipeline."

In October 2018, the Company received U.S. Food and Drug Administration (FDA) clearance for its first product, dualX – the Dual Expanding Interbody Fusion System. DualX is comprised of a family of titanium expandable interbody devices designed to be used in transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF) and lateral lumbar interbody fusion (LLIF) spinal procedures. The product portfolio contains varying footprints, heights and degrees of lordosis with post-expansion bone grafting to provide a customized, anatomical fit for a clinically-successful fusion environment.

The Company officially changed its name in January and has begun the rebranding process. The Company anticipates the rebranding process will continue through the end of the first quarter.

About Amplify Surgical Amplify Surgical, Inc. is a privately-held spinal device company located in Mission Viejo, CA. The Company focuses on developing and commercializing innovative, minimally-invasive technologies for spine surgery. Amplify Surgical is a portfolio company of IntuitiveX, a life science innovation incubator.

 

SOURCE Innovasive Inc



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store